LB
Liisa Bayko Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
8
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
75%
Neutral
25%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $12 |
11%
downside
| 1 | +62% |
0
%
| 15 Sep ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $475 |
1%
upside
| 1 | +21% |
0
%
| 11 Sep ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $515.05 |
29%
upside
| 1 | -15% |
0
%
| 11 Sep ‘25 3 months ago |
|
|
|
In-Line
Maintained
| $2 |
65%
downside
| 2 | – |
–
| 28 May ‘25 7 months ago |
|
|
|
Outperform
Upgraded
| $99 |
76%
upside
| 1 | +30% |
0
%
| 14 Feb ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $45 |
26%
upside
| 1 | +50% |
0
%
| 12 Feb ‘25 11 months ago |
|
|
|
Outperform
Maintained
| $12 |
57%
upside
| 1 | -0.65% |
0
%
| 13 Jan ‘25 1 year ago |
|